Switch/sucrose nonfermentable (SWI/SNF) complexes are ATP-dependent chromatin remodeler complexes that play critical roles in timely and appropriate gene regulation by modulating chromatin architecture and DNA accessibility. SWI/SNF complexes can be grouped into three subcomplexes of differing sizes, canonical BAF (cBAF), polybromo BAF (PBAF), and newly identified noncanonical BAF (ncBAF). The most recently characterized ncBAF lacks the core BAF subunits ARID, BAF47, and BAF57, but includes unique subunits GLTSCR1/1L and BRD9, one of the bromodomain-containing proteins.We recently demonstrated the novel mechanism for the ncBAF disruption caused by mutations in a spiceosomal protein, SF3B1, especially in 65–83% for myelodysplastic syndromes (MDS) with ring sideroblasts as well as in >20% of mucosal/uveal melanomas, suggesting that the disturbed ncBAF may have some roles in the malignant hematopoiesis.
More...Switch/sucrose nonfermentable (SWI/SNF) complexes are ATP-dependent chromatin remodeler complexes that play critical roles in timely and appropriate gene regulation by modulating chromatin architecture and DNA accessibility. SWI/SNF complexes can be grouped into three subcomplexes of differing sizes, canonical BAF (cBAF), polybromo BAF (PBAF), and newly identified noncanonical BAF (ncBAF). The most recently characterized ncBAF lacks the core BAF subunits ARID, BAF47, and BAF57, but includes unique subunits GLTSCR1/1L and BRD9, one of the bromodomain-containing proteins.We recently demonstrated the novel mechanism for the ncBAF disruption caused by mutations in a spiceosomal protein, SF3B1, especially in 65–83% for myelodysplastic syndromes (MDS) with ring sideroblasts as well as in >20% of mucosal/uveal melanomas, suggesting that the disturbed ncBAF may have some roles in the malignant hematopoiesis.Mechanistically, SF3B1 mutant recognizes an aberrant, deep intronic branchpoint within BRD9 and thereby induces the inclusion of an aberrant exon and subsequently profound degradation of BRD9 mRNA by triggering nonsense-mediated RNA decay (NMD). However, compared to the roles of cBAF, the functions of BRD9/ncBAF in normal and malignant hematopoiesis in vivo have been totally uncharacterized.
Overall design: The MOLM13 cell lines were cultured in RPMI with 10% FCS and 1% P/S to the logarithmic growth phase, treated MOLM13 cells with DMSO and 50nM dBRD9 for 4 days and abstract RNA for RNA-seq.
Less...Accession | PRJNA993185; GEO: GSE236960 |
Type | Umbrella project |
Publications | Xiao M et al., "BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state.", Nat Commun, 2023 Dec 15;14(1):8372 |
Submission | Registration date: 10-Jul-2023 Department of Hematology-Oncology, Foundation for Biomedical Research and Innovation at Kobe |
Relevance | Superseries |
Project Data:
Resource Name | Number of Links |
---|
Sequence data |
SRA Experiments | 10 |
Publications |
PubMed | 1 |
PMC | 1 |
Other datasets |
BioSample | 10 |
GEO DataSets | 3 |
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state encompasses the following 2 sub-projects:
Project Type | Number of Projects |
Epigenomics | 1 |
BioProject accession | Organism | Title |
---|
PRJNA993189 | Mus musculus | BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state [Mouse_Brd9_CTCF ChIP-seq] (Department of Hematology-Oncology,...) |
|
Transcriptome or Gene expression | 1 |
BioProject accession | Organism | Title |
---|
PRJNA993190 | Homo sapiens | BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state [MOLM13 DMSO vs dBRD9 RNA-seq] (Department of Hematology-Oncology,...) |
|